Forget daily pills. This shot works when blood pressure meds fail

A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood pressure reductions than those on standard treatment alone. The drug works by blocking a key liver protein, helping blood vessels relax. Researchers say this long-lasting approach could make it much easier for patients to keep their condition under control.

from Latest Science News -- ScienceDaily https://ift.tt/fKcsI72

Forget daily pills. This shot works when blood pressure meds fail

A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood pressure reductions than those on standard treatment alone. The drug works by blocking a key liver protein, helping blood vessels relax. Researchers say this long-lasting approach could make it much easier for patients to keep their condition under control.

from Top Health News -- ScienceDaily https://ift.tt/fKcsI72

Hidden weak spots in HIV and Ebola revealed with breakthrough nanodisc technology

A new nanodisc-based platform lets scientists study viral proteins in a form that closely mimics real viruses, revealing how antibodies truly recognize them. This approach uncovered hidden interactions in viruses like HIV and Ebola that traditional methods missed. By recreating the virus’s membrane environment, researchers can better understand how immune defenses work. The technique could speed up the development of more effective vaccines.

from Top Health News -- ScienceDaily https://ift.tt/MunC962

The Universe is expanding too fast and scientists still can’t explain it

A major international effort has produced an ultra-precise measurement of the Universe’s expansion rate, confirming it’s faster than early-Universe models predict. By linking multiple distance-measuring techniques, scientists ruled out simple errors as the cause of the discrepancy. The persistent “Hubble tension” now looks more real than ever. It could mean our current model of the cosmos is incomplete.

from Latest Science News -- ScienceDaily https://ift.tt/irU7EKx

Scientists finally crack mystery of rare COVID vaccine blood clots

Researchers have uncovered why a rare blood clotting disorder can occur after certain COVID-19 vaccines or adenovirus infections. The immune system can mistakenly target a normal blood protein (PF4) after confusing it with a viral protein. This triggers clotting in extremely rare cases. The breakthrough means vaccines can now be redesigned to avoid this reaction while staying effective.

from Latest Science News -- ScienceDaily https://ift.tt/75ywWQO

Scientists finally uncover why promising cancer drugs keep failing

Cancer drugs known as BET inhibitors once looked like a breakthrough, but in real patients they’ve often fallen short. New research reveals a key reason why: two closely related proteins, BRD2 and BRD4, don’t actually do the same job. Instead, BRD2 acts like a “stage manager,” preparing genes for activation, while BRD4 triggers the final step that turns them on. By blocking both at once, current drugs may be disrupting the process in unpredictable ways.

from Latest Science News -- ScienceDaily https://ift.tt/D5k7Eq3

Scientists just found a hidden “drain” inside the human brain

A hidden waste-removal pathway in the brain has finally been caught in action. Using cutting-edge MRI scans, researchers discovered that fluid flows along the middle meningeal artery in a slow, lymphatic-like pattern—very different from blood. This confirms the presence of a previously unknown drainage hub in humans. The finding could transform how scientists approach brain aging, injury, and diseases like Alzheimer’s.

from Latest Science News -- ScienceDaily https://ift.tt/hGp4sbB